Share Price and Basic Stock Data
Last Updated: January 17, 2026, 12:51 pm
| PEG Ratio | 5.98 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Vinati Organics Ltd operates in the chemicals sector, specifically focusing on benzene-based organic chemicals. As of the latest reporting period, the company’s stock price stood at ₹1,596, with a market capitalization of ₹16,577 Cr. The firm has exhibited a strong revenue growth trajectory, with sales increasing from ₹1,616 Cr in FY 2022 to ₹2,066 Cr in FY 2023, reflecting a significant year-on-year growth. For FY 2025, sales are projected to reach ₹2,248 Cr, showcasing the company’s robust operational capabilities. Quarterly sales in the latest fiscal year showed a slight decline in Q2 FY 2024, reporting ₹439 Cr, but rebounded to ₹463 Cr in Q3 FY 2024. The overall trend indicates resilience in revenue generation, supported by a diverse product portfolio and strategic market positioning.
Profitability and Efficiency Metrics
Vinati Organics reported a healthy operating profit margin (OPM) of 33% as of the latest fiscal year, which is notably higher than the sector average, indicating effective cost management and pricing power. The net profit for FY 2023 was recorded at ₹465 Cr, with a net profit margin of 18.02% for FY 2025. The company’s return on equity (ROE) stood at 15.8%, while return on capital employed (ROCE) was 20.6%, both of which are commendable figures compared to typical sector benchmarks. The interest coverage ratio (ICR) of 1202.37x signifies an exceptional ability to cover interest obligations, indicating low financial risk. However, the cash conversion cycle (CCC) of 119 days highlights potential inefficiencies in working capital management, which could be an area for improvement.
Balance Sheet Strength and Financial Ratios
Vinati Organics has maintained a robust balance sheet, with total reserves increasing to ₹2,960 Cr as of September 2025, showcasing strong retained earnings and financial stability. The company reported zero borrowings, reflecting a debt-free status that enhances its financial flexibility. The price-to-book value (P/BV) ratio stood at 5.86x, suggesting a premium valuation in comparison to book value, which is indicative of investor confidence in the company’s growth prospects. Financial ratios reveal a current ratio of 3.31x and a quick ratio of 2.61x, both of which are significantly above the industry average, indicating strong liquidity. However, the inventory turnover ratio of 10.71x suggests efficient inventory management, which is critical for sustaining profitability in the chemicals sector.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Vinati Organics reveals a strong promoter holding of 74.29%, which reflects confidence in the company’s long-term strategy and stability. The presence of foreign institutional investors (FIIs) has decreased slightly to 3.77%, while domestic institutional investors (DIIs) have increased their stake to 9.55%, indicating growing institutional interest. The total number of shareholders stood at 85,005, showing a diversified ownership base that can enhance liquidity. The dividend payout ratio for FY 2025 is set at 17.90%, suggesting a balanced approach between rewarding shareholders and reinvesting in growth. However, the gradual decline in FIIs may raise concerns regarding the stock’s appeal to international investors, which could impact liquidity and valuation.
Outlook, Risks, and Final Insight
Looking ahead, Vinati Organics is well-positioned to capitalize on the growing demand for organic chemicals, particularly in the context of increasing global sustainability initiatives. However, external risks such as fluctuations in raw material prices and regulatory changes in the chemicals sector could pose challenges. Additionally, the company’s reliance on a few key products may expose it to market volatility. Strengths include its strong balance sheet, high profitability margins, and efficient operations, which should support continued growth. Conversely, potential risks include the need for improved working capital management and the impact of reduced foreign investment. Overall, while Vinati Organics shows significant promise, investors should remain vigilant regarding market dynamics and operational efficiencies.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Hindustan Organic Chemicals Ltd | 218 Cr. | 32.4 | 45.0/22.4 | 152 | 0.00 % | 5.20 % | 21.6 % | 10.0 | |
| Vinati Organics Ltd | 16,324 Cr. | 1,575 | 2,040/1,412 | 35.1 | 287 | 0.48 % | 20.6 % | 15.8 % | 1.00 |
| Seya Industries Ltd | 46.6 Cr. | 17.5 | 27.4/12.6 | 309 | 0.00 % | 0.51 % | 0.77 % | 10.0 | |
| Industry Average | 8,271.00 Cr | 541.63 | 35.10 | 249.33 | 0.16% | 8.77% | 12.72% | 7.00 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 566 | 517 | 519 | 439 | 463 | 448 | 550 | 525 | 553 | 522 | 648 | 542 | 546 |
| Expenses | 418 | 369 | 372 | 338 | 358 | 333 | 400 | 400 | 419 | 379 | 465 | 376 | 368 |
| Operating Profit | 148 | 148 | 147 | 100 | 105 | 115 | 150 | 125 | 134 | 143 | 184 | 166 | 179 |
| OPM % | 26% | 29% | 28% | 23% | 23% | 26% | 27% | 24% | 24% | 27% | 28% | 31% | 33% |
| Other Income | 20 | 11 | 12 | 10 | 11 | 9 | 10 | 9 | 22 | 7 | 6 | 7 | 16 |
| Interest | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 13 | 17 | 17 | 17 | 17 | 19 | 19 | 20 | 21 | 20 | 20 | 21 | 22 |
| Profit before tax | 155 | 142 | 142 | 93 | 97 | 103 | 140 | 114 | 136 | 129 | 169 | 151 | 173 |
| Tax % | 25% | 25% | 26% | 25% | 25% | 25% | 25% | 25% | 22% | 26% | 25% | 26% | 25% |
| Net Profit | 116 | 107 | 105 | 69 | 72 | 77 | 104 | 86 | 106 | 96 | 128 | 113 | 129 |
| EPS in Rs | 11.29 | 10.40 | 10.18 | 6.75 | 7.05 | 7.49 | 10.08 | 8.30 | 10.24 | 9.22 | 12.31 | 10.88 | 12.45 |
Last Updated: December 28, 2025, 2:33 pm
Below is a detailed analysis of the quarterly data for Vinati Organics Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 546.00 Cr.. The value appears strong and on an upward trend. It has increased from 542.00 Cr. (Jun 2025) to 546.00 Cr., marking an increase of 4.00 Cr..
- For Expenses, as of Sep 2025, the value is 368.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 376.00 Cr. (Jun 2025) to 368.00 Cr., marking a decrease of 8.00 Cr..
- For Operating Profit, as of Sep 2025, the value is 179.00 Cr.. The value appears strong and on an upward trend. It has increased from 166.00 Cr. (Jun 2025) to 179.00 Cr., marking an increase of 13.00 Cr..
- For OPM %, as of Sep 2025, the value is 33.00%. The value appears strong and on an upward trend. It has increased from 31.00% (Jun 2025) to 33.00%, marking an increase of 2.00%.
- For Other Income, as of Sep 2025, the value is 16.00 Cr.. The value appears strong and on an upward trend. It has increased from 7.00 Cr. (Jun 2025) to 16.00 Cr., marking an increase of 9.00 Cr..
- For Interest, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.00 Cr..
- For Depreciation, as of Sep 2025, the value is 22.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 21.00 Cr. (Jun 2025) to 22.00 Cr., marking an increase of 1.00 Cr..
- For Profit before tax, as of Sep 2025, the value is 173.00 Cr.. The value appears strong and on an upward trend. It has increased from 151.00 Cr. (Jun 2025) to 173.00 Cr., marking an increase of 22.00 Cr..
- For Tax %, as of Sep 2025, the value is 25.00%. The value appears to be improving (decreasing) as expected. It has decreased from 26.00% (Jun 2025) to 25.00%, marking a decrease of 1.00%.
- For Net Profit, as of Sep 2025, the value is 129.00 Cr.. The value appears strong and on an upward trend. It has increased from 113.00 Cr. (Jun 2025) to 129.00 Cr., marking an increase of 16.00 Cr..
- For EPS in Rs, as of Sep 2025, the value is 12.45. The value appears strong and on an upward trend. It has increased from 10.88 (Jun 2025) to 12.45, marking an increase of 1.57.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 4:25 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 696 | 772 | 631 | 641 | 730 | 1,128 | 1,029 | 954 | 1,616 | 2,066 | 1,900 | 2,248 | 2,259 |
| Expenses | 543 | 580 | 424 | 423 | 531 | 703 | 614 | 601 | 1,180 | 1,493 | 1,429 | 1,662 | 1,588 |
| Operating Profit | 153 | 192 | 207 | 218 | 198 | 425 | 415 | 353 | 435 | 573 | 471 | 587 | 671 |
| OPM % | 22% | 25% | 33% | 34% | 27% | 38% | 40% | 37% | 27% | 28% | 25% | 26% | 30% |
| Other Income | 9 | 9 | 6 | 12 | 31 | 30 | 45 | 26 | 61 | 52 | 39 | 44 | 36 |
| Interest | 18 | 10 | 8 | 3 | 2 | 2 | 2 | 1 | 2 | 3 | 5 | 2 | 1 |
| Depreciation | 15 | 18 | 19 | 22 | 23 | 27 | 33 | 43 | 45 | 59 | 73 | 81 | 83 |
| Profit before tax | 129 | 174 | 187 | 206 | 203 | 425 | 425 | 335 | 449 | 563 | 432 | 548 | 623 |
| Tax % | 33% | 33% | 29% | 32% | 29% | 34% | 21% | 20% | 23% | 26% | 25% | 24% | |
| Net Profit | 86 | 116 | 132 | 140 | 144 | 282 | 334 | 269 | 347 | 419 | 323 | 415 | 465 |
| EPS in Rs | 8.75 | 11.22 | 12.75 | 13.59 | 14.00 | 27.48 | 32.48 | 26.20 | 33.73 | 40.78 | 31.19 | 40.05 | 44.86 |
| Dividend Payout % | 17% | 16% | 16% | 2% | 16% | 13% | 17% | 23% | 19% | 17% | 22% | 19% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 34.88% | 13.79% | 6.06% | 2.86% | 95.83% | 18.44% | -19.46% | 29.00% | 20.75% | -22.91% | 28.48% |
| Change in YoY Net Profit Growth (%) | 0.00% | -21.09% | -7.73% | -3.20% | 92.98% | -77.39% | -37.90% | 48.46% | -8.25% | -43.66% | 51.39% |
Vinati Organics Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 17% |
| 3 Years: | 12% |
| TTM: | 14% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 14% |
| 5 Years: | 4% |
| 3 Years: | 6% |
| TTM: | 30% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 22% |
| 5 Years: | 12% |
| 3 Years: | -9% |
| 1 Year: | -9% |
| Return on Equity | |
|---|---|
| 10 Years: | 20% |
| 5 Years: | 18% |
| 3 Years: | 17% |
| Last Year: | 16% |
Last Updated: September 5, 2025, 1:51 pm
Balance Sheet
Last Updated: January 7, 2026, 4:46 pm
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
| Reserves | 300 | 424 | 530 | 670 | 786 | 1,041 | 1,269 | 1,533 | 1,851 | 2,203 | 2,454 | 2,796 | 2,960 |
| Borrowings | 162 | 65 | 42 | 2 | 15 | 4 | 0 | 2 | 28 | 35 | 5 | 63 | -0 |
| Other Liabilities | 80 | 100 | 104 | 139 | 168 | 173 | 163 | 188 | 260 | 335 | 358 | 394 | 350 |
| Total Liabilities | 552 | 599 | 687 | 821 | 980 | 1,228 | 1,443 | 1,734 | 2,150 | 2,584 | 2,827 | 3,263 | 3,320 |
| Fixed Assets | 304 | 327 | 382 | 468 | 457 | 475 | 751 | 757 | 874 | 1,159 | 1,330 | 1,382 | 1,341 |
| CWIP | 10 | 20 | 25 | 7 | 35 | 191 | 31 | 55 | 306 | 229 | 246 | 298 | 372 |
| Investments | 3 | 3 | 3 | 62 | 132 | 96 | 227 | 289 | 98 | 256 | 237 | 523 | 776 |
| Other Assets | 235 | 249 | 278 | 284 | 356 | 465 | 434 | 633 | 872 | 940 | 1,014 | 1,059 | 831 |
| Total Assets | 552 | 599 | 687 | 821 | 980 | 1,228 | 1,443 | 1,734 | 2,150 | 2,584 | 2,827 | 3,263 | 3,320 |
Below is a detailed analysis of the balance sheet data for Vinati Organics Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 10.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 10.00 Cr..
- For Reserves, as of Sep 2025, the value is 2,960.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,796.00 Cr. (Mar 2025) to 2,960.00 Cr., marking an increase of 164.00 Cr..
- For Borrowings, as of Sep 2025, the value is 0.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 63.00 Cr. (Mar 2025) to 0.00 Cr., marking a decrease of 63.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 350.00 Cr.. The value appears to be improving (decreasing). It has decreased from 394.00 Cr. (Mar 2025) to 350.00 Cr., marking a decrease of 44.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 3,320.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3,263.00 Cr. (Mar 2025) to 3,320.00 Cr., marking an increase of 57.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 1,341.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,382.00 Cr. (Mar 2025) to 1,341.00 Cr., marking a decrease of 41.00 Cr..
- For CWIP, as of Sep 2025, the value is 372.00 Cr.. The value appears strong and on an upward trend. It has increased from 298.00 Cr. (Mar 2025) to 372.00 Cr., marking an increase of 74.00 Cr..
- For Investments, as of Sep 2025, the value is 776.00 Cr.. The value appears strong and on an upward trend. It has increased from 523.00 Cr. (Mar 2025) to 776.00 Cr., marking an increase of 253.00 Cr..
- For Other Assets, as of Sep 2025, the value is 831.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,059.00 Cr. (Mar 2025) to 831.00 Cr., marking a decrease of 228.00 Cr..
- For Total Assets, as of Sep 2025, the value is 3,320.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,263.00 Cr. (Mar 2025) to 3,320.00 Cr., marking an increase of 57.00 Cr..
Notably, the Reserves (2,960.00 Cr.) exceed the Borrowings (0.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -9.00 | 127.00 | 165.00 | 216.00 | 183.00 | 421.00 | 415.00 | 351.00 | 407.00 | 538.00 | 466.00 | 524.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 60 | 61 | 66 | 80 | 89 | 79 | 72 | 106 | 102 | 82 | 102 | 96 |
| Inventory Days | 41 | 44 | 55 | 79 | 79 | 64 | 79 | 115 | 85 | 79 | 72 | 66 |
| Days Payable | 12 | 17 | 28 | 40 | 61 | 37 | 47 | 62 | 52 | 41 | 36 | 43 |
| Cash Conversion Cycle | 89 | 87 | 94 | 119 | 107 | 106 | 104 | 158 | 136 | 120 | 137 | 119 |
| Working Capital Days | 45 | 58 | 60 | 118 | 113 | 111 | 97 | 138 | 144 | 109 | 140 | 107 |
| ROCE % | 30% | 38% | 36% | 33% | 28% | 46% | 37% | 24% | 26% | 27% | 19% | 21% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| Aditya Birla Sun Life Flexi Cap Fund | 1,387,969 | 0.88 | 219.26 | N/A | N/A | N/A |
| Canara Robeco Large and Mid Cap Fund | 1,232,048 | 0.74 | 194.63 | N/A | N/A | N/A |
| Aditya Birla Sun Life ELSS Tax Saver Fund | 774,862 | 0.78 | 122.41 | N/A | N/A | N/A |
| Canara Robeco Flexi Cap Fund | 718,956 | 0.82 | 113.57 | 711,456 | 2025-12-15 02:18:58 | 1.05% |
| HSBC Small Cap Fund | 622,492 | 0.61 | 98.34 | N/A | N/A | N/A |
| ICICI Prudential Multi Asset Fund | 594,254 | 0.13 | 93.87 | 517,669 | 2025-12-15 02:18:58 | 14.79% |
| Aditya Birla Sun Life Multi-Cap Fund | 521,879 | 1.22 | 82.44 | N/A | N/A | N/A |
| Canara Robeco ELSS Tax Saver Fund | 490,300 | 0.85 | 77.45 | 215,300 | 2025-11-03 10:07:01 | 127.73% |
| Canara Robeco Equity Hybrid Fund | 484,724 | 0.67 | 76.57 | 338,000 | 2025-11-03 10:07:01 | 43.41% |
| Quant Small Cap Fund | 362,211 | 0.19 | 57.22 | N/A | N/A | N/A |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Basic EPS (Rs.) | 39.09 | 31.15 | 44.56 | 33.72 | 26.20 |
| Diluted EPS (Rs.) | 39.09 | 31.15 | 44.56 | 33.72 | 26.20 |
| Cash EPS (Rs.) | 47.62 | 38.19 | 49.61 | 38.15 | 30.38 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 269.36 | 221.98 | 215.82 | 177.85 | 150.16 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 269.36 | 221.98 | 215.82 | 177.85 | 150.16 |
| Revenue From Operations / Share (Rs.) | 216.80 | 183.28 | 202.83 | 157.18 | 92.84 |
| PBDIT / Share (Rs.) | 60.29 | 49.05 | 64.98 | 48.16 | 36.81 |
| PBIT / Share (Rs.) | 51.76 | 42.02 | 59.92 | 43.73 | 32.64 |
| PBT / Share (Rs.) | 51.70 | 41.67 | 59.86 | 43.71 | 32.62 |
| Net Profit / Share (Rs.) | 39.08 | 31.15 | 44.56 | 33.72 | 26.20 |
| NP After MI And SOA / Share (Rs.) | 39.08 | 31.15 | 44.56 | 33.72 | 26.20 |
| PBDIT Margin (%) | 27.81 | 26.76 | 32.03 | 30.64 | 39.65 |
| PBIT Margin (%) | 23.87 | 22.92 | 29.54 | 27.82 | 35.15 |
| PBT Margin (%) | 23.84 | 22.73 | 29.51 | 27.80 | 35.13 |
| Net Profit Margin (%) | 18.02 | 16.99 | 21.96 | 21.45 | 28.22 |
| NP After MI And SOA Margin (%) | 18.02 | 16.99 | 21.96 | 21.45 | 28.22 |
| Return on Networth / Equity (%) | 14.50 | 14.03 | 20.64 | 18.96 | 17.44 |
| Return on Capital Employeed (%) | 18.09 | 16.61 | 26.46 | 23.38 | 20.61 |
| Return On Assets (%) | 12.35 | 11.37 | 17.98 | 16.58 | 15.53 |
| Total Debt / Equity (X) | 0.02 | 0.00 | 0.00 | 0.01 | 0.00 |
| Asset Turnover Ratio (%) | 0.73 | 0.70 | 0.89 | 0.84 | 0.60 |
| Current Ratio (X) | 3.31 | 4.53 | 4.52 | 4.64 | 6.15 |
| Quick Ratio (X) | 2.61 | 3.62 | 3.65 | 3.59 | 5.01 |
| Inventory Turnover Ratio (X) | 10.71 | 5.19 | 5.93 | 5.74 | 3.87 |
| Dividend Payout Ratio (NP) (%) | 17.90 | 22.27 | 14.58 | 17.79 | 1.90 |
| Dividend Payout Ratio (CP) (%) | 14.69 | 18.17 | 13.10 | 15.72 | 1.64 |
| Earning Retention Ratio (%) | 82.10 | 77.73 | 85.42 | 82.21 | 98.10 |
| Cash Earning Retention Ratio (%) | 85.31 | 81.83 | 86.90 | 84.28 | 98.36 |
| Interest Coverage Ratio (X) | 1202.37 | 140.04 | 1064.81 | 1913.39 | 1785.59 |
| Interest Coverage Ratio (Post Tax) (X) | 780.33 | 89.94 | 731.19 | 1340.85 | 1271.98 |
| Enterprise Value (Cr.) | 16441.23 | 15241.12 | 18575.21 | 20078.18 | 14384.14 |
| EV / Net Operating Revenue (X) | 7.31 | 8.02 | 8.91 | 12.43 | 15.07 |
| EV / EBITDA (X) | 26.30 | 29.97 | 27.81 | 40.56 | 38.02 |
| MarketCap / Net Operating Revenue (X) | 7.29 | 8.03 | 8.92 | 12.42 | 15.08 |
| Retention Ratios (%) | 82.09 | 77.72 | 85.41 | 82.20 | 98.09 |
| Price / BV (X) | 5.86 | 6.63 | 8.38 | 10.98 | 9.32 |
| Price / Net Operating Revenue (X) | 7.29 | 8.03 | 8.92 | 12.42 | 15.08 |
| EarningsYield | 0.02 | 0.02 | 0.02 | 0.01 | 0.01 |
After reviewing the key financial ratios for Vinati Organics Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 39.09. This value is within the healthy range. It has increased from 31.15 (Mar 24) to 39.09, marking an increase of 7.94.
- For Diluted EPS (Rs.), as of Mar 25, the value is 39.09. This value is within the healthy range. It has increased from 31.15 (Mar 24) to 39.09, marking an increase of 7.94.
- For Cash EPS (Rs.), as of Mar 25, the value is 47.62. This value is within the healthy range. It has increased from 38.19 (Mar 24) to 47.62, marking an increase of 9.43.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 269.36. It has increased from 221.98 (Mar 24) to 269.36, marking an increase of 47.38.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 269.36. It has increased from 221.98 (Mar 24) to 269.36, marking an increase of 47.38.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 216.80. It has increased from 183.28 (Mar 24) to 216.80, marking an increase of 33.52.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 60.29. This value is within the healthy range. It has increased from 49.05 (Mar 24) to 60.29, marking an increase of 11.24.
- For PBIT / Share (Rs.), as of Mar 25, the value is 51.76. This value is within the healthy range. It has increased from 42.02 (Mar 24) to 51.76, marking an increase of 9.74.
- For PBT / Share (Rs.), as of Mar 25, the value is 51.70. This value is within the healthy range. It has increased from 41.67 (Mar 24) to 51.70, marking an increase of 10.03.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 39.08. This value is within the healthy range. It has increased from 31.15 (Mar 24) to 39.08, marking an increase of 7.93.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 39.08. This value is within the healthy range. It has increased from 31.15 (Mar 24) to 39.08, marking an increase of 7.93.
- For PBDIT Margin (%), as of Mar 25, the value is 27.81. This value is within the healthy range. It has increased from 26.76 (Mar 24) to 27.81, marking an increase of 1.05.
- For PBIT Margin (%), as of Mar 25, the value is 23.87. This value exceeds the healthy maximum of 20. It has increased from 22.92 (Mar 24) to 23.87, marking an increase of 0.95.
- For PBT Margin (%), as of Mar 25, the value is 23.84. This value is within the healthy range. It has increased from 22.73 (Mar 24) to 23.84, marking an increase of 1.11.
- For Net Profit Margin (%), as of Mar 25, the value is 18.02. This value exceeds the healthy maximum of 10. It has increased from 16.99 (Mar 24) to 18.02, marking an increase of 1.03.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 18.02. This value is within the healthy range. It has increased from 16.99 (Mar 24) to 18.02, marking an increase of 1.03.
- For Return on Networth / Equity (%), as of Mar 25, the value is 14.50. This value is below the healthy minimum of 15. It has increased from 14.03 (Mar 24) to 14.50, marking an increase of 0.47.
- For Return on Capital Employeed (%), as of Mar 25, the value is 18.09. This value is within the healthy range. It has increased from 16.61 (Mar 24) to 18.09, marking an increase of 1.48.
- For Return On Assets (%), as of Mar 25, the value is 12.35. This value is within the healthy range. It has increased from 11.37 (Mar 24) to 12.35, marking an increase of 0.98.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.02. This value is within the healthy range. It has increased from 0.00 (Mar 24) to 0.02, marking an increase of 0.02.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.73. It has increased from 0.70 (Mar 24) to 0.73, marking an increase of 0.03.
- For Current Ratio (X), as of Mar 25, the value is 3.31. This value exceeds the healthy maximum of 3. It has decreased from 4.53 (Mar 24) to 3.31, marking a decrease of 1.22.
- For Quick Ratio (X), as of Mar 25, the value is 2.61. This value exceeds the healthy maximum of 2. It has decreased from 3.62 (Mar 24) to 2.61, marking a decrease of 1.01.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 10.71. This value exceeds the healthy maximum of 8. It has increased from 5.19 (Mar 24) to 10.71, marking an increase of 5.52.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 17.90. This value is below the healthy minimum of 20. It has decreased from 22.27 (Mar 24) to 17.90, marking a decrease of 4.37.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 14.69. This value is below the healthy minimum of 20. It has decreased from 18.17 (Mar 24) to 14.69, marking a decrease of 3.48.
- For Earning Retention Ratio (%), as of Mar 25, the value is 82.10. This value exceeds the healthy maximum of 70. It has increased from 77.73 (Mar 24) to 82.10, marking an increase of 4.37.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 85.31. This value exceeds the healthy maximum of 70. It has increased from 81.83 (Mar 24) to 85.31, marking an increase of 3.48.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 1,202.37. This value is within the healthy range. It has increased from 140.04 (Mar 24) to 1,202.37, marking an increase of 1,062.33.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 780.33. This value is within the healthy range. It has increased from 89.94 (Mar 24) to 780.33, marking an increase of 690.39.
- For Enterprise Value (Cr.), as of Mar 25, the value is 16,441.23. It has increased from 15,241.12 (Mar 24) to 16,441.23, marking an increase of 1,200.11.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 7.31. This value exceeds the healthy maximum of 3. It has decreased from 8.02 (Mar 24) to 7.31, marking a decrease of 0.71.
- For EV / EBITDA (X), as of Mar 25, the value is 26.30. This value exceeds the healthy maximum of 15. It has decreased from 29.97 (Mar 24) to 26.30, marking a decrease of 3.67.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 7.29. This value exceeds the healthy maximum of 3. It has decreased from 8.03 (Mar 24) to 7.29, marking a decrease of 0.74.
- For Retention Ratios (%), as of Mar 25, the value is 82.09. This value exceeds the healthy maximum of 70. It has increased from 77.72 (Mar 24) to 82.09, marking an increase of 4.37.
- For Price / BV (X), as of Mar 25, the value is 5.86. This value exceeds the healthy maximum of 3. It has decreased from 6.63 (Mar 24) to 5.86, marking a decrease of 0.77.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 7.29. This value exceeds the healthy maximum of 3. It has decreased from 8.03 (Mar 24) to 7.29, marking a decrease of 0.74.
- For EarningsYield, as of Mar 25, the value is 0.02. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.02.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Vinati Organics Ltd:
- Net Profit Margin: 18.02%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 18.09% (Industry Average ROCE: 8.77%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 14.5% (Industry Average ROE: 12.72%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 780.33
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 2.61
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 35.1 (Industry average Stock P/E: 35.1)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.02
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 18.02%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Chemicals - Organic - Benzene Based | B-12 & B-13/1, MIDC Industrial Area, Raigad District Maharashtra 402309 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Vinod Saraf | Chairman |
| Ms. Vinati Saraf Mutreja | Managing Director & CEO |
| Mr. Amit Thanawala | Whole Time Director |
| Prof. M Lakshmi Kantam | Independent Director |
| Mr. J C Laddha | Independent Director |
| Ms. Viral Saraf Mittal | Director - Corporate Strategy |
| Mrs. Mona Bhide | Independent Director |
| Dr. Prashant Barve | Independent Director |
FAQ
What is the intrinsic value of Vinati Organics Ltd?
Vinati Organics Ltd's intrinsic value (as of 18 January 2026) is ₹1354.52 which is 14.00% lower the current market price of ₹1,575.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹16,324 Cr. market cap, FY2025-2026 high/low of ₹2,040/1,412, reserves of ₹2,960 Cr, and liabilities of ₹3,320 Cr.
What is the Market Cap of Vinati Organics Ltd?
The Market Cap of Vinati Organics Ltd is 16,324 Cr..
What is the current Stock Price of Vinati Organics Ltd as on 18 January 2026?
The current stock price of Vinati Organics Ltd as on 18 January 2026 is ₹1,575.
What is the High / Low of Vinati Organics Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Vinati Organics Ltd stocks is ₹2,040/1,412.
What is the Stock P/E of Vinati Organics Ltd?
The Stock P/E of Vinati Organics Ltd is 35.1.
What is the Book Value of Vinati Organics Ltd?
The Book Value of Vinati Organics Ltd is 287.
What is the Dividend Yield of Vinati Organics Ltd?
The Dividend Yield of Vinati Organics Ltd is 0.48 %.
What is the ROCE of Vinati Organics Ltd?
The ROCE of Vinati Organics Ltd is 20.6 %.
What is the ROE of Vinati Organics Ltd?
The ROE of Vinati Organics Ltd is 15.8 %.
What is the Face Value of Vinati Organics Ltd?
The Face Value of Vinati Organics Ltd is 1.00.